help button home button Endocrine Society JCEM JCEM Call for Nominations for EIC
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Article
Right arrow Submit a related Letter to the Editor
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Turnbull, D. M.
Right arrow Articles by Hall, R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Turnbull, D. M.
Right arrow Articles by Hall, R.

Journal of Clinical Endocrinology & Metabolism, Vol 51, 930-933, Copyright © 1980 by Endocrine Society

ARTICLES

Hormonal and metabolic studies in a patient with a pheochromocytoma

DM Turnbull, DG Johnston, KG Alberti and R Hall

The metabolic and hormonal responses to oral glucose were studied in a patient with a pheochromocytoma before treatment, after alpha-blockade, after combined alpha- and beta-blockade, and after surgical removal of the tumor. Before treatment, fasting blood glucose was elevated [6.5 mmol/liter (117 mg/dl); normal range, 4.2--5.5 mmol/liter (75--100 mg/dl)], as was the fasting plasma nonesterified fatty acid level (1.19 mmol/liter; normal range, 0.06--0.7 mmol/liter), the blood total ketone body concentration (0.50 mmol/liter; normal range, 0.02--0.44 mmol/liter) and the lactate ot pyruvate ratio (16.2; normal range, 5.9-- 15.01. These abnormalities were corrected by alpha-adrenergic blockade alone and together with beta-blockade. Oral glucose tolerance (50 g) was mildly impaired in the untreated state, and the insulin response was decreased. Both alpha- and alpha- plus beta-blockade restored the insulin response to glucose but failed to correct the glucose intolerance. Three months after removal of the tumor, all metabolic findings were normal. The correction of the fasting metabolite concentrations and serum insulin levels by alpha-adrenergic blockade suggests that an alpha-adenergic effect causes the original metabolic abnormalities. The residual glucose intolerance after adrenergic blockade may result from incomplete blockade or factors other than alpha- and beta-adrenergic activity.


This article has been cited by other articles:


Home page
 Ann. N. Y. Acad. Sci.Home page
E. ZAPANTI and I. ILIAS
Pheochromocytoma: Physiopathologic Implications and Diagnostic Evaluation
Ann. N.Y. Acad. Sci., November 1, 2006; 1088(1): 346 - 360.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
T. D. Wiesner, M. Bluher, M. Windgassen, and R. Paschke
Improvement of Insulin Sensitivity after Adrenalectomy in Patients with Pheochromocytoma
J. Clin. Endocrinol. Metab., August 1, 2003; 88(8): 3632 - 3636.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 1980 by The Endocrine Society